• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心房功能障碍是经颈静脉肝内门体分流术治疗的肝硬化患者死亡率的独立预测因子。

Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt.

机构信息

Department of CardiologyLeiden University Medical CenterLeidenthe Netherlands.

Department of Cardiovascular MedicineFondazione Policlinico Universitario A. Gemelli IRCSSRomeItaly.

出版信息

Hepatol Commun. 2022 Nov;6(11):3163-3174. doi: 10.1002/hep4.2062. Epub 2022 Aug 27.

DOI:10.1002/hep4.2062
PMID:36029167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9592786/
Abstract

The present study aimed to investigate (1) the association between left ventricular diastolic dysfunction (LVDD), graded according to the algorithm proposed by the Cirrhotic Cardiomyopathy Consortium, and long-term survival in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS) and (2) the additive prognostic value of left atrial (LA) function, as assessed by LA reservoir strain, using two-dimensional speckle-tracking echocardiography (2D-STE). A total of 129 TIPS candidates (mean ± SD, 61 ± 12 years; 61% men) underwent a comprehensive preprocedural echocardiography. LA dysfunction was defined by LA reservoir strain ≤35%, based on a previously suggested cut-off value. The outcome was all-cause mortality after TIPS. In the current cohort, 65 (50%) patients had normal diastolic function, 26 (20%) patients had grade 1 LVDD, 21 (16%) patients had grade 2 LVDD, and 17 (13%) patients had indeterminate diastolic function. Additionally, LA dysfunction (based on LA reservoir strain ≤35%) was noted in 67 (52%) patients. After a median follow-up of 36 months (range, 12-80), 65 (50%) patients died. All-cause mortality rates increased along worse grades of LVDD (log-rank p = 0.007) and with LA dysfunction (log-rank p = 0.001). On multivariable Cox regression analysis, Model for End-Stage Liver Disease score (hazard ratio [HR],1.06; p = 0.003), hemoglobin (HR, 0.74; p = 0.022), and LA strain, expressed as a continuous variable (HR, 0.96; p = 0.005) were independently associated with all-cause mortality. Notably, the addition of LA strain to the model provided incremental prognostic value over the established prognostic variables (delta χ  = 8.27, p = 0.004). Conclusion: LA dysfunction assessed with 2D-STE is independently associated with all-cause mortality in patients with cirrhosis treated by TIPS.

摘要

本研究旨在探讨(1)根据肝硬化心肌病联盟提出的算法分级的左心室舒张功能障碍(LVDD)与接受经颈静脉肝内门体分流术(TIPS)的肝硬化患者的长期生存之间的关系;(2)使用二维斑点追踪超声心动图(2D-STE)评估左心房(LA)功能的左心房储备应变的附加预后价值。共有 129 名 TIPS 候选者(平均 ± 标准差,61 ± 12 岁;61%为男性)接受了全面的术前超声心动图检查。根据先前提出的截断值,将 LA 储备应变≤35%定义为 LA 功能障碍。该研究的转归是 TIPS 后的全因死亡率。在当前队列中,65 名(50%)患者舒张功能正常,26 名(20%)患者存在 1 级 LVDD,21 名(16%)患者存在 2 级 LVDD,17 名(13%)患者存在不确定的舒张功能。此外,在 67 名(52%)患者中观察到 LA 功能障碍(基于 LA 储备应变≤35%)。中位随访 36 个月(范围,12-80)后,65 名(50%)患者死亡。随着 LVDD 等级恶化(对数秩检验 p=0.007)和 LA 功能障碍(对数秩检验 p=0.001),全因死亡率增加。多变量 Cox 回归分析显示,终末期肝病模型评分(HR,1.06;p=0.003)、血红蛋白(HR,0.74;p=0.022)和 LA 应变(HR,0.96;p=0.005)与全因死亡率独立相关。值得注意的是,与既定的预后变量相比,LA 应变的加入提供了增量预后价值(增量 χ 2=8.27,p=0.004)。结论:使用 2D-STE 评估的 LA 功能障碍与接受 TIPS 治疗的肝硬化患者的全因死亡率独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/9592786/91378b0e02b6/HEP4-6-3163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/9592786/b3649fc88e0d/HEP4-6-3163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/9592786/4b6e77d97741/HEP4-6-3163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/9592786/a2d81d124f9e/HEP4-6-3163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/9592786/91378b0e02b6/HEP4-6-3163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/9592786/b3649fc88e0d/HEP4-6-3163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/9592786/4b6e77d97741/HEP4-6-3163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/9592786/a2d81d124f9e/HEP4-6-3163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/9592786/91378b0e02b6/HEP4-6-3163-g005.jpg

相似文献

1
Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt.左心房功能障碍是经颈静脉肝内门体分流术治疗的肝硬化患者死亡率的独立预测因子。
Hepatol Commun. 2022 Nov;6(11):3163-3174. doi: 10.1002/hep4.2062. Epub 2022 Aug 27.
2
Transjugular intrahepatic portosystemic shunt in refractory ascites: clinical impact of left ventricular diastolic dysfunction.经颈静脉肝内门体分流术治疗难治性腹水:左心室舒张功能障碍的临床影响。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e464-e470. doi: 10.1097/MEG.0000000000002151.
3
The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.使用E/A比值作为经颈静脉肝内门体分流术治疗的肝硬化患者预后的预测指标。
Am J Gastroenterol. 2009 Oct;104(10):2458-66. doi: 10.1038/ajg.2009.321. Epub 2009 Jun 16.
4
Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.超声心动图显示舒张功能障碍不能预测肝硬化经颈静脉肝内门体分流支架植入术后患者的生存。
Aliment Pharmacol Ther. 2019 Mar;49(6):797-806. doi: 10.1111/apt.15164. Epub 2019 Feb 17.
5
Left atrial strain and ventricular global longitudinal strain in cirrhotic patients using the new criteria of Cirrhotic Cardiomyopathy Consortium.使用肝硬化心肌病联盟新标准的肝硬化患者的左心房应变和心室整体纵向应变。
Liver Int. 2023 Dec;43(12):2727-2742. doi: 10.1111/liv.15714. Epub 2023 Aug 29.
6
Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis.舒张功能障碍与肝硬化患者经颈静脉肝内门体分流术后心脏失代偿有关。
United European Gastroenterol J. 2023 Nov;11(9):837-851. doi: 10.1002/ueg2.12471. Epub 2023 Oct 28.
7
Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.左心室舒张功能障碍与肝硬化患者的肾功能不全、生存率低及健康相关生活质量差有关。
J Clin Exp Hepatol. 2019 May-Jun;9(3):324-333. doi: 10.1016/j.jceh.2018.08.008. Epub 2018 Aug 30.
8
Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis.经颈静脉肝内门体分流术植入后肝硬化患者疾病进展的预测:一项性别分层分析。
World J Gastroenterol. 2023 Nov 14;29(42):5768-5780. doi: 10.3748/wjg.v29.i42.5768.
9
Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.舒张功能障碍与经颈静脉肝内门体分流术的肝硬化患者生存率低相关。
Gut. 2007 Jun;56(6):869-75. doi: 10.1136/gut.2006.102467. Epub 2006 Nov 29.
10
Diagnosis and Management of Cirrhotic Cardiomyopathy.肝硬化性心肌病的诊断与管理
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):186-199. doi: 10.1016/j.jceh.2021.08.016. Epub 2021 Aug 21.

引用本文的文献

1
Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.肝硬化患者经颈静脉肝内门体分流术后的心血管风险评估及心脏失代偿的预测因素
World J Gastroenterol. 2025 Jul 21;31(27):107740. doi: 10.3748/wjg.v31.i27.107740.
2
EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implications.欧洲肝脏研究学会研究生课程报告:慢性肝病中的血管生物学及其临床管理意义
JHEP Rep. 2025 Mar 19;7(8):101399. doi: 10.1016/j.jhepr.2025.101399. eCollection 2025 Aug.
3
Early Dynamics of Portal Pressure Gradient After TIPS Insertion Predict Mortality.
经颈静脉肝内门体分流术(TIPS)置入后门静脉压力梯度的早期动态变化可预测死亡率。
Aliment Pharmacol Ther. 2025 Apr;61(7):1175-1182. doi: 10.1111/apt.18503. Epub 2025 Jan 16.
4
Racial and Ethnic Disparities in Outcomes After the Development of Ascites: A National Cohort Study.种族和民族差异在腹水发展后的结局:一项全国队列研究。
Dig Dis Sci. 2024 Sep;69(9):3214-3219. doi: 10.1007/s10620-024-08572-w. Epub 2024 Jul 30.
5
Unveiling the impact of cirrhotic cardiomyopathy on portal hemodynamics and survival after transjugular intrahepatic portosystemic shunt: a prospective study.揭示肝硬化性心肌病对经颈静脉肝内门体分流术后门脉血液动力学和生存的影响:一项前瞻性研究。
Abdom Radiol (NY). 2024 Oct;49(10):3507-3516. doi: 10.1007/s00261-024-04446-x. Epub 2024 Jun 20.
6
Evaluation and clinical significance of contrast-enhanced ultrasound on changes in liver blood flow perfusion after TIPS surgery.经颈静脉肝内门体分流术(TIPS)后肝血流灌注变化的超声造影评估及其临床意义。
Medicine (Baltimore). 2024 Apr 26;103(17):e37899. doi: 10.1097/MD.0000000000037899.
7
The Contemporary Role of Speckle Tracking Echocardiography in Cirrhotic Cardiomyopathy.斑点追踪超声心动图在肝硬化性心肌病中的当代作用
Life (Basel). 2024 Jan 25;14(2):179. doi: 10.3390/life14020179.
8
Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting.经颈静脉肝内门体分流术在肝移植中的作用。
J Clin Med. 2024 Jan 21;13(2):600. doi: 10.3390/jcm13020600.
9
Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis.舒张功能障碍与肝硬化患者经颈静脉肝内门体分流术后心脏失代偿有关。
United European Gastroenterol J. 2023 Nov;11(9):837-851. doi: 10.1002/ueg2.12471. Epub 2023 Oct 28.
10
How non-alcoholic fatty liver disease and cirrhosis affect the heart.非酒精性脂肪性肝病和肝硬化如何影响心脏。
Hepatol Int. 2023 Dec;17(6):1333-1349. doi: 10.1007/s12072-023-10590-1. Epub 2023 Sep 28.